Media advisory - Neurochem's Annual and Special Meeting of Shareholders April 15, 2008

LAVAL, QC, April 11 /PRNewswire-FirstCall/ - Dr. Francesco Bellini, Chairman, President and Chief Executive Officer of Neurochem Inc., invites the news media to the Annual and Special Meeting of Shareholders to be held on Tuesday, April 15, 2008, at 10:00 A.M., in the Maxwell-Cummings Auditorium of the Michal and Renata Hornstein Pavilion of the Montreal Museum of Fine Arts, 1379 Sherbrooke Street West, Montreal, Quebec.

Immediately following the meeting, Dr. Bellini and members of senior management will be available for questions from the news media.

SOURCE NEUROCHEM INC.

Suggested Articles

Xevinapant in combination with standard cisplatin-based chemoradiation therapy (CRT) reduces the risk of death in high-risk patients with locally adva

Ironwood had once hyped this drug as a $2 billion-a-year asset, but IW-3718 has failed to live up to its high expectations.

Junshi’s PD-1 blocker is already approved in China for metastatic melanoma, but the Shanghai-based biotech may soon add throat cancer to its label.